-
1
-
-
84862070781
-
Endothelial cells and thrombotic microangiopathy
-
Motto D. Endothelial cells and thrombotic microangiopathy. Semin Nephrol. 2012;32(2):208-214.
-
(2012)
Semin Nephrol
, vol.32
, Issue.2
, pp. 208-214
-
-
Motto, D.1
-
2
-
-
84863841323
-
Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies
-
Scully M, Hunt BJ, Benjamin S, et al. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol. 2012;158(3):323-335.
-
(2012)
Br J Haematol
, vol.158
, Issue.3
, pp. 323-335
-
-
Scully, M.1
Hunt, B.J.2
Benjamin, S.3
-
3
-
-
84874193062
-
Evaluation of patients with microangiopathic hemolytic anemia and thrombocytopenia
-
George JN and Charania RS. Evaluation of patients with microangiopathic hemolytic anemia and thrombocytopenia. Semin Thromb Hemost. 2013;39(2):153-160.
-
(2013)
Semin Thromb Hemost
, vol.39
, Issue.2
, pp. 153-160
-
-
George, J.N.1
Charania, R.S.2
-
4
-
-
33645456286
-
Complications of therapeutic plasma exchange: Experience with 4857 treatments
-
Basic-Jukic N, Kes P, Glavas-Boras S, Brunetta B, Bubic-Filipi L, Puretic Z. Complications of therapeutic plasma exchange: experience with 4857 treatments. Ther Apher Dial. 2005;9(5):391-395.
-
(2005)
Ther Apher Dial
, vol.9
, Issue.5
, pp. 391-395
-
-
Basic-Jukic, N.1
Kes, P.2
Glavas-Boras, S.3
Brunetta, B.4
Bubic-Filipi, L.5
Puretic, Z.6
-
5
-
-
84886405720
-
Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP)
-
Shah N, Rutherford C, Matevosyan K, Shen YM, Sarode R. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP). Br J Haematol. 2013;163(4):514-519.
-
(2013)
Br J Haematol
, vol.163
, Issue.4
, pp. 514-519
-
-
Shah, N.1
Rutherford, C.2
Matevosyan, K.3
Shen, Y.M.4
Sarode, R.5
-
6
-
-
84881381644
-
Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: The sixth special issue
-
Schwartz J, Winters JL, Padmanabhan A, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher. 2013;28(3):145-284.
-
(2013)
J Clin Apher
, vol.28
, Issue.3
, pp. 145-284
-
-
Schwartz, J.1
Winters, J.L.2
Padmanabhan, A.3
-
7
-
-
25144446865
-
The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: All patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency
-
Terrell DR, Williams LA, Vesely SK, Lammle B, Hovinga JA, George JN. The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. J Thromb Haemost. 2005;3(7):1432-1436.
-
(2005)
J Thromb Haemost
, vol.3
, Issue.7
, pp. 1432-1436
-
-
Terrell, D.R.1
Williams, L.A.2
Vesely, S.K.3
Lammle, B.4
Hovinga, J.A.5
George, J.N.6
-
8
-
-
0026048114
-
Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura
-
Rock GA, Shumak KH, Buskard NA, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med. 1991;325(6):393-397.
-
(1991)
Canadian Apheresis Study Group. N Engl J Med
, vol.325
, Issue.6
, pp. 393-397
-
-
Rock, G.A.1
Shumak, K.H.2
Buskard, N.A.3
-
9
-
-
84862783878
-
The use of ADAMTS13 activity, platelet count, and serum creatinine to differentiate acquired thrombotic thrombocytopenic purpura from other thrombotic microangiopathies
-
Cataland SR, Yang S, Wu HM. The use of ADAMTS13 activity, platelet count, and serum creatinine to differentiate acquired thrombotic thrombocytopenic purpura from other thrombotic microangiopathies. Br J Haematol. 2012;157(4):501-503.
-
(2012)
Br J Haematol
, vol.157
, Issue.4
, pp. 501-503
-
-
Cataland, S.R.1
Yang, S.2
Wu, H.M.3
-
10
-
-
0032569884
-
Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolyticuremic syndrome
-
Furlan M, Robles R, Galbusera M, et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolyticuremic syndrome. N Engl J Med. 1998;339(22):1578-1584.
-
(1998)
N Engl J Med
, vol.339
, Issue.22
, pp. 1578-1584
-
-
Furlan, M.1
Robles, R.2
Galbusera, M.3
-
11
-
-
0032569840
-
Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura
-
Tsai HM and Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med. 1998;339(22):1585-1594.
-
(1998)
N Engl J Med
, vol.339
, Issue.22
, pp. 1585-1594
-
-
Tsai, H.M.1
Lian, E.C.2
-
12
-
-
0035807348
-
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
-
Levy GG, Nichols WC, Lian EC, et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature. 2001;413(6855):488-494.
-
(2001)
Nature
, vol.413
, Issue.6855
, pp. 488-494
-
-
Levy, G.G.1
Nichols, W.C.2
Lian, E.C.3
-
13
-
-
84856998772
-
Thrombotic microangiopathies, thrombotic thrombocytopenic purpura, and ADAMTS-13
-
Chapman K, Seldon M, Richards R. Thrombotic microangiopathies, thrombotic thrombocytopenic purpura, and ADAMTS-13. Semin Thromb Hemost. 2012;38(1):47-54.
-
(2012)
Semin Thromb Hemost
, vol.38
, Issue.1
, pp. 47-54
-
-
Chapman, K.1
Seldon, M.2
Richards, R.3
-
14
-
-
61849116707
-
Integrin alpha(v)beta(3) on human endothelial cells binds von Willebrand factor strings under fluid shear stress
-
Huang J, Roth R, Heuser JE, Sadler JE. Integrin alpha(v)beta(3) on human endothelial cells binds von Willebrand factor strings under fluid shear stress. Blood. 2009;113(7):1589-1597.
-
(2009)
Blood
, vol.113
, Issue.7
, pp. 1589-1597
-
-
Huang, J.1
Roth, R.2
Heuser, J.E.3
Sadler, J.E.4
-
15
-
-
2542490269
-
Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura
-
Zheng XL, Kaufman RM, Goodnough LT, Sadler JE. Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura. Blood. 2004;103(11):4043-4049.
-
(2004)
Blood
, vol.103
, Issue.11
, pp. 4043-4049
-
-
Zheng, X.L.1
Kaufman, R.M.2
Goodnough, L.T.3
Sadler, J.E.4
-
16
-
-
0037968640
-
ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Relation to presenting features and clinical outcomes in a prospective cohort of 142 patients
-
Vesely SK, George JN, Lammle B, et al. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood. 2003;102(1):60-68.
-
(2003)
Blood
, vol.102
, Issue.1
, pp. 60-68
-
-
Vesely, S.K.1
George, J.N.2
Lammle, B.3
-
17
-
-
84870902189
-
Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency
-
George JN, Chen Q, Deford CC, Al-Nouri Z. Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency. J Clin Apher. 2012;27(6):302-311.
-
(2012)
J Clin Apher
, vol.27
, Issue.6
, pp. 302-311
-
-
George, J.N.1
Chen, Q.2
Deford, C.C.3
Al-Nouri, Z.4
-
18
-
-
34147136218
-
Hyperbilirubinemia interferes with ADAMTS-13 activity measurement by FRETSVWF73 assay: Diagnostic relevance in patients suffering from acute thrombotic microangiopathies
-
Meyer SC, Sulzer I, Lammle B, Kremer Hovinga JA. Hyperbilirubinemia interferes with ADAMTS-13 activity measurement by FRETSVWF73 assay: diagnostic relevance in patients suffering from acute thrombotic microangiopathies. J Thromb Haemost. 2007;5(4):866-867.
-
(2007)
J Thromb Haemost
, vol.5
, Issue.4
, pp. 866-867
-
-
Meyer, S.C.1
Sulzer, I.2
Lammle, B.3
Kremer Hovinga, J.A.4
-
19
-
-
84904095940
-
Congenital and acquired thrombotic thrombocytopenic purpura and pregnancy: Presentation, management and outcome of subsequent pregnancies
-
Scully M, Thomas M, Underwood M, et al. Congenital and acquired thrombotic thrombocytopenic purpura and pregnancy: presentation, management and outcome of subsequent pregnancies. Blood. 2014;124(2):211-219.
-
(2014)
Blood
, vol.124
, Issue.2
, pp. 211-219
-
-
Scully, M.1
Thomas, M.2
Underwood, M.3
-
21
-
-
84864876679
-
Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: Case-control study
-
Menne J, Nitschke M, Stingele R, et al. Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ. 2012;345:e4565.
-
(2012)
BMJ
, vol.345
, pp. e4565
-
-
Menne, J.1
Nitschke, M.2
Stingele, R.3
-
23
-
-
0036331717
-
Invasive pneumococcal disease and hemolytic uremic syndrome
-
Brandt J, Wong C, Mihm S, et al. Invasive pneumococcal disease and hemolytic uremic syndrome. Pediatrics. 2002;110(2 Pt 1):371-376.
-
(2002)
Pediatrics
, vol.110
, Issue.2
, pp. 371-376
-
-
Brandt, J.1
Wong, C.2
Mihm, S.3
-
24
-
-
84886030991
-
Identification of TLR4 as the receptor that recognizes Shiga toxins in human neutrophils
-
Brigotti M, Carnicelli D, Arfilli V, et al. Identification of TLR4 as the receptor that recognizes Shiga toxins in human neutrophils. J Immunol. 2013;191(9):4748-4758.
-
(2013)
J Immunol
, vol.191
, Issue.9
, pp. 4748-4758
-
-
Brigotti, M.1
Carnicelli, D.2
Arfilli, V.3
-
25
-
-
1542330038
-
Pneumococcusinduced T-antigen activation in hemolytic uremic syndrome and anemia
-
Cochran JB, Panzarino VM, Maes LY, Tecklenburg FW. Pneumococcusinduced T-antigen activation in hemolytic uremic syndrome and anemia. Pediatr Nephrol. 2004;19(3):317-321.
-
(2004)
Pediatr Nephrol
, vol.19
, Issue.3
, pp. 317-321
-
-
Cochran, J.B.1
Panzarino, V.M.2
Maes, L.Y.3
Tecklenburg, F.W.4
-
26
-
-
0025359141
-
Escherichia coli O157:H7 and the hemolytic uremic syndrome: Importance of early cultures in establishing the etiology
-
Tarr PI, Neill MA, Clausen CR, Watkins SL, Christie DL, Hickman RO. Escherichia coli O157:H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology. J Infect Dis. 1990;162(2):553-556.
-
(1990)
J Infect Dis
, vol.162
, Issue.2
, pp. 553-556
-
-
Tarr, P.I.1
Neill, M.A.2
Clausen, C.R.3
Watkins, S.L.4
Christie, D.L.5
Hickman, R.O.6
-
27
-
-
0034972253
-
Von Willebrand factor-cleaving protease in childhood diarrhoea-associated haemolytic uraemic syndrome
-
Hunt BJ, Lammle B, Nevard CH, Haycock GB, Furlan M. von Willebrand factor-cleaving protease in childhood diarrhoea-associated haemolytic uraemic syndrome. Thromb Haemost. 2001;85(6):975-978.
-
(2001)
Thromb Haemost
, vol.85
, Issue.6
, pp. 975-978
-
-
Hunt, B.J.1
Lammle, B.2
Nevard, C.H.3
Haycock, G.B.4
Furlan, M.5
-
28
-
-
84879402878
-
Role of ADAMTS13 in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura
-
Kremer Hovinga JA and Lammle B. Role of ADAMTS13 in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program. 2012;2012:610-616.
-
(2012)
Hematology Am Soc Hematol Educ Program
, vol.2012
, pp. 610-616
-
-
Kremer Hovinga, J.A.1
Lammle, B.2
-
29
-
-
84867993202
-
Renal and neurological involvement in typical Shiga toxin-associated HUS
-
Trachtman H, Austin C, Lewinski M, Stahl RA. Renal and neurological involvement in typical Shiga toxin-associated HUS. Nat Rev Nephrol. 2012;8(11):658-669.
-
(2012)
Nat Rev Nephrol
, vol.8
, Issue.11
, pp. 658-669
-
-
Trachtman, H.1
Austin, C.2
Lewinski, M.3
Stahl, R.A.4
-
30
-
-
77958587405
-
Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype
-
Noris M, Caprioli J, Bresin E, et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol. 2010;5(10):1844-1859.
-
(2010)
Clin J Am Soc Nephrol
, vol.5
, Issue.10
, pp. 1844-1859
-
-
Noris, M.1
Caprioli, J.2
Bresin, E.3
-
31
-
-
75749153964
-
Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome
-
Bienaime F, Dragon-Durey MA, Regnier CH, et al. Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome. Kidney Int. 2010;77(4):339-349.
-
(2010)
Kidney Int
, vol.77
, Issue.4
, pp. 339-349
-
-
Bienaime, F.1
Dragon-Durey, M.A.2
Regnier, C.H.3
-
32
-
-
54049137505
-
Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome
-
Fremeaux-Bacchi V, Miller EC, Liszewski MK, et al. Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood. 2008;112(13):4948-4952.
-
(2008)
Blood
, vol.112
, Issue.13
, pp. 4948-4952
-
-
Fremeaux-Bacchi, V.1
Miller, E.C.2
Liszewski, M.K.3
-
33
-
-
79953691827
-
Mutations in complement regulatory proteins predispose to preeclampsia: A genetic analysis of the PROMISSE cohort
-
Salmon JE, Heuser C, Triebwasser M, et al. Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort. PLoS Med. 2011;8(3):e1001013.
-
(2011)
PLoS Med
, vol.8
, Issue.3
, pp. e1001013
-
-
Salmon, J.E.1
Heuser, C.2
Triebwasser, M.3
-
34
-
-
84884526601
-
The role of complement in Streptococcus pneumoniae-associated haemolytic uraemic syndrome
-
Szilagyi A, Kiss N, Bereczki C, et al. The role of complement in Streptococcus pneumoniae-associated haemolytic uraemic syndrome. Nephrol Dial Transplant. 2013;28(9):2237-2245.
-
(2013)
Nephrol Dial Transplant
, vol.28
, Issue.9
, pp. 2237-2245
-
-
Szilagyi, A.1
Kiss, N.2
Bereczki, C.3
-
35
-
-
84885717017
-
Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy
-
Jodele S, Licht C, Goebel J, et al. Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy. Blood. 2013;122(12): 2003-2007.
-
(2013)
Blood
, vol.122
, Issue.12
, pp. 2003-2007
-
-
Jodele, S.1
Licht, C.2
Goebel, J.3
-
36
-
-
34548313714
-
Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome
-
Kavanagh D, Richards A, Fremeaux-Bacchi V, et al. Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol. 2007;2(3):591-596.
-
(2007)
Clin J Am Soc Nephrol
, vol.2
, Issue.3
, pp. 591-596
-
-
Kavanagh, D.1
Richards, A.2
Fremeaux-Bacchi, V.3
-
37
-
-
84902589905
-
Biomarkers of the alternative pathway and terminal complement activity at presentation confirms the clinical diagnosis of aHUS and differentiates aHUS from TTP
-
Cataland SR, Holers VM, Geyer S, Yang S, Wu HM. Biomarkers of the alternative pathway and terminal complement activity at presentation confirms the clinical diagnosis of aHUS and differentiates aHUS from TTP. Blood. 2014;123(24):3733-3738.
-
(2014)
Blood
, vol.123
, Issue.24
, pp. 3733-3738
-
-
Cataland, S.R.1
Holers, V.M.2
Geyer, S.3
Yang, S.4
Wu, H.M.5
-
38
-
-
84867993256
-
Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies
-
French Study Group for aHUS/C3G
-
Zuber J, Fakhouri F, Roumenina LT, Loirat C, Fremeaux-Bacchi V, French Study Group for aHUS/C3G. Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies. Nat Rev Nephrol. 2012;8(11):643-657.
-
(2012)
Nat Rev Nephrol
, vol.8
, Issue.11
, pp. 643-657
-
-
Zuber, J.1
Fakhouri, F.2
Roumenina, L.T.3
Loirat, C.4
Fremeaux-Bacchi, V.5
|